Anticoagulant Therapy for Disseminated Intravascular Coagulation After Gastrointestinal Surgery
Daisuke Hashimoto1,2, Takaomi Okawa2, Riichiroh Maruyama3
1Department of Gastroenterological Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan daisukeh007@gmail.com.
Insights
Anticoagulant therapy for disseminated intravascular coagulation (DIC) after gastrointestinal surgery shows promise. Agents like gabexate mesylate, antithrombin, and recombinant thrombomodulin appear effective and safe, improving outcomes without significant bleeding risks.
Area of Science:
- Medical research
- Pharmacology
- Gastroenterology
Background:
- Disseminated intravascular coagulation (DIC) following gastrointestinal surgery presents unique challenges.
- Distinguishing surgery-related DIC from other forms is crucial for effective treatment.
- Anticoagulant therapy's efficacy and safety in this context require careful evaluation due to bleeding risks.
Purpose of the Study:
- To systematically review the efficacy and safety of anticoagulant agents for treating DIC specifically after gastrointestinal surgery.
- To clarify the benefits and risks associated with different anticoagulant options in this patient population.
Main Methods:
- Systematic literature review of studies on anticoagulant therapy for post-gastrointestinal surgery DIC.
- Analysis of data on DIC scores, bleeding events, and mortality rates.
Main Results:
- Gabexate mesylate demonstrated improvement in DIC scores without increased bleeding.
- Antithrombin was linked to reduced mortality in patients with DIC post-gastrointestinal surgery.
- Recombinant thrombomodulin showed improved DIC scores and survival rates, with no increase in bleeding events.
Conclusions:
- Anticoagulant therapy is a potentially effective and safe treatment strategy for DIC occurring after gastrointestinal surgery.
- Specific agents like recombinant thrombomodulin show particular promise in improving patient outcomes.
Abstract:
Many studies about anticoagulant therapy for disseminated intravascular coagulation (DIC) confused gastrointestinal surgery-related DIC with DIC unrelated to a prior operation. Furthermore, the potentially increased risk of bleeding by anticoagulants complicates their use. We carried out a systematic review to describe the efficacy and safety of anticoagulant agents for DIC after gastrointestinal surgery. Several studies have indicated that gabexate mesylate improves DIC score without increasing bleeding events, and that antithrombin is associated with lower mortality of DIC after gastrointestinal surgery. Recombinant thrombomodulin has been the most frequently analyzed anticoagulant agent in this field. DIC score and survival rate were better in patients treated with recombinant thrombomodulin, without increasing bleeding events. In conclusion, anticoagulant therapy may be effective and safe in DIC after gastrointestinal surgery.
Related Concept Videos
Coagulation
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anatomy of the Gastrointestinal System
Here's a detailed walkthrough of this complex system:
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Gastrointestinal Motility Disorders


